Fragrance Moderation And Wholesale Reliance Will Temper Benefits From APAC And Derma Expansion

Catalysts

About Puig Brands

Puig is a global premium beauty group focused on fragrances, makeup and skincare, with brands such as Carolina Herrera, Charlotte Tilbury, Byredo and several derma labels.

What are the underlying business or industry changes driving this perspective?

• Although Charlotte Tilbury continues to gain traction across makeup and skincare, the current surge from Amazon U.S. sell in and selective new country entries may prove hard to repeat at the same intensity. This could soften revenue growth in this segment once distribution effects normalise and shift the burden back to underlying demand to sustain earnings.
• While the premium and niche fragrance category has been growing faster than the broader market for more than a decade and Byredo is described as an engine of growth, category moderation and retailer focus on inventory discipline could limit the pace at which Puig converts this favorable mix into higher net revenue and may cap margin expansion if launch costs remain high.
• Despite strong like for like growth in APAC and the region being underpenetrated at only 10% of group net revenue, the move from distributors to subsidiaries increases operational complexity and fixed cost. Any slowdown from current growth levels could pressure net margins until scale efficiencies fully offset the added overhead.
• Although expanding Charlotte Tilbury through tightly controlled door openings and scarcity has supported brand heat, the cautious rollout means that the benefit from clear white space in major regions like LatAm and parts of Europe may materialise more gradually. This could temper the contribution of this brand to consolidated revenue and earnings over the next planning cycle.
• While derma skincare and premium makeup trends support Puig's mix, the heavy reliance on the wholesale channel at about 90% of the business leaves the group exposed to retailer open to buy decisions and potential stock adjustments after peak seasons. This could introduce volatility into reported net revenue and limit the visibility of margin progression.

Assumptions

This narrative explores a more pessimistic perspective on Puig Brands compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts. How have these above catalysts been quantified?

• The bearish analysts are assuming Puig Brands's revenue will grow by 3.2% annually over the next 3 years.
• The bearish analysts assume that profit margins will shrink from 13.3% today to 11.7% in 3 years time.
• The bearish analysts expect earnings to reach €634.0 million (and earnings per share of €1.12) by about January 2029, down from €651.8 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as €799.0 million.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 16.0x on those 2029 earnings, up from 13.1x today. This future PE is lower than the current PE for the ES Personal Products industry at 22.6x.
• The bearish analysts expect the number of shares outstanding to remain consistent over the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.82%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Charlotte Tilbury is still early in its global rollout, with new doors on Amazon U.S., fresh entries in markets like Mexico and continued white space across LatAm and major European countries. A sustained expansion in distribution and new product launches could support higher long term revenue and earnings than implied by a flat share price view.
• The Niche fragrance category has been growing faster than the broader market for more than 10 years and Puig highlights double digit year to date growth for its own Niche brands, with Byredo described as an engine of growth. This could support mix driven net revenue and margin resilience that is not reflected in expectations for a stagnant share price.
• APAC accounts for only 10% of Puig net revenue yet is the fastest growing region with 23% like for like growth over the first nine months and benefits from subsidiary consolidation. Continued penetration gains in this underrepresented region could lift consolidated revenue and, over time, earnings.
• Management reiterates a full year 2025 like for like growth outlook of 6% to 8% and signals confidence in adjusted EBITDA margin expansion versus 2024. If these trends persist beyond the current year, the combination of revenue growth and improving margins could challenge the assumption that the share price will simply move sideways.
• Although fragrance market growth is moderating, Puig still reports like for like growth ahead of the global premium beauty market, with blockbusters such as Carolina Herrera La Bomba showing early promise without cannibalizing Good Girl. This could support longer term category share and therefore support net revenue and earnings more than a flat share price implies.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Puig Brands is €14.0, which represents up to two standard deviations below the consensus price target of €19.28. This valuation is based on what can be assumed as the expectations of Puig Brands's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €26.6, and the most bearish reporting a price target of just €14.0.
  
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be €5.4 billion, earnings will come to €634.0 million, and it would be trading on a PE ratio of 16.0x, assuming you use a discount rate of 8.8%.
  
• Given the current share price of €15.21, the analyst price target of €14.0 is 8.6% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.